help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, J.
Right arrow Articles by Tashjian, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, J.
Right arrow Articles by Tashjian, A. H., Jr

Endocrinology, Vol 133, 487-490, Copyright © 1993 by Endocrine Society

ARTICLES

Transcriptional regulation by dexamethasone of endogenous thyrotropin- releasing hormone receptor messenger ribonucleic acid in rat pituitary GH4C1 cells

J Yang and AH Tashjian Jr
Department of Molecular and Cellular Toxicology, Harvard School of Public Health, Boston, Massachusetts 02115.

Previous molecular studies on the mechanism of regulation of TRH receptor (TRHR) mRNA used transfected cells and concluded that the major mode of regulation is via mRNA degradation. Glucocorticoid hormones induce an increase in the number of TRHRs in rat pituitary GH cells, the model system used most extensively to characterize these receptors. We prepared a probe from the recently cloned rat lactotroph TRHR cDNA and investigated the mechanism of regulation by dexamethasone of endogenous TRHR mRNA in GH4C1 cells. Incubation with dexamethasone (100 nM for 6-48 h) induced a 3-to 4-fold increase in the steady state TRHR mRNA concentration (maximum at 24 h), as determined by Northern blot analysis. The stimulation was specific for glucocorticoids and dose dependent over the range 1-500 nM (maximum effect reached at 10 nM). The rate of transcription of the TRHR gene, measured by a nuclear run-on assay, was increased 3.0 +/- 0.57-fold (mean +/- SE) in cells treated for 12 h with 100 nM dexamethasone. We conclude that glucocorticoids regulate endogenous TRHR mRNA expression in GH4C1 cells in large part by controlling the rate of transcription of the TRHR gene.


This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
E. A. Nillni and K. A. Sevarino
The Biology of pro-Thyrotropin-Releasing Hormone-Derived Peptides
Endocr. Rev., October 1, 1999; 20(5): 599 - 648.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
T. Iwasaki, M. Yamada, T. Satoh, S. Konaka, Y. Ren, K. Hashimoto, H. Kohga, Y. Kato, and M. Mori
Genomic Organization and Promoter Function of the Human Thyrotropin-releasing Hormone Receptor Gene
J. Biol. Chem., September 6, 1996; 271(36): 22183 - 22188.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society